Resmed Inc (RMD) financials

Resmed Inc (RMD) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2026, Resmed Inc reported revenue of $5.65B, up 9.9% year over year, net income of $1.52B, diluted EPS of $10.43 and free cash flow of $1.65B.

Revenue (fiscal 2026)

$5.65B

Revenue growth (fiscal 2026)

9.9%

Net income (fiscal 2026)

$1.52B

Diluted EPS (fiscal 2026)

$10.43

Free cash flow (fiscal 2026)

$1.65B

Resmed Inc files with the U.S. Securities and Exchange Commission under CIK 0000943819, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.